tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Myriad Genetics sees FY26 revenue $860M-$880M, consensus $869.3M
PremiumThe FlyMyriad Genetics sees FY26 revenue $860M-$880M, consensus $869.3M
1M ago
Myriad Genetics price target lowered to $7 from $9 at TD Cowen
Premium
The Fly
Myriad Genetics price target lowered to $7 from $9 at TD Cowen
2M ago
Myriad Genetics management to meet virtually with Craig-Hallum
Premium
The Fly
Myriad Genetics management to meet virtually with Craig-Hallum
3M ago
Myriad Genetics trading halted, volatility trading pause
PremiumThe FlyMyriad Genetics trading halted, volatility trading pause
4M ago
Myriad Genetics price target raised to $9 from $8 at TD Cowen
Premium
The Fly
Myriad Genetics price target raised to $9 from $8 at TD Cowen
4M ago
Myriad Genetics price target raised to $8 from $6 at UBS
Premium
The Fly
Myriad Genetics price target raised to $8 from $6 at UBS
4M ago
Is MYGN a Buy, Before Earnings?
PremiumPre-EarningsIs MYGN a Buy, Before Earnings?
4M ago
Myriad Genetics Advances in Metastatic Cancer Treatment Study
Premium
Company Announcements
Myriad Genetics Advances in Metastatic Cancer Treatment Study
4M ago
Myriad Genetics adds F8, FXN genest to Foresight Universal Plus Panel
Premium
The Fly
Myriad Genetics adds F8, FXN genest to Foresight Universal Plus Panel
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100